MedTrace Logo

e-BioMatrix Canada Registry

NCT01915628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 535

Last updated 2019-05-07

No results posted yet for this study

Summary

Prospective, multi-center registry to be conducted at 6 Canadian interventional cardiology centers. The e-BioMatrix data will be compared with a historical control group, the Cypher arm of the Biosensors Leaders study consisting of 313 patients. All patients will be followed for up to 2 years.

Conditions

  • Device Related MACE and Bleeding

Interventions

DEVICE

BioMatrix Flex

Percutaneous coronary intervention

Sponsors & Collaborators

  • Biosensors Europe SA

    lead INDUSTRY

Principal Investigators

  • Luc Bilodeau, MD · Royal Victoria Hospital, Montreal, Canada

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2016-09-30
Completion
2017-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01915628 on ClinicalTrials.gov